Fortis Healthcare (India) has acquired a majority stake in Singapore based diagnostic firm.
Fortis Healthcare Singapore, Fortis’ offshore subsidiary, has acquired 85 per cent stake in RadLink-Asia for Singapore dollar 62.9 million (approx Rs 245 crore). RadLink-Asia is an outpatient diagnostic and molecular imaging chain in Singapore. The transaction will provide Fortis Healthcare a strong foothold in the premium diagnostics and molecular imaging segment in Singapore.
